SCHEMBL6280285

SCHEMBL6280285

COc1cc(SCC(=O)c2ccccc2)ccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
ALDH1A1 P00352 5/20 0.54
LMNA P02545 5/20 0.54
RAB9A P51151 4/20 0.54
GCGR P47871 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 4/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
HTT P42858 2/20 0.49
HPGD P15428 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CYP3A4 P08684 1/20 0.47
RECQL P46063 1/20 0.47
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46
TP53 P04637 1/20 0.46
ALOX12 P18054 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6281258 0.90 MAPT (0.56) MAPTALDH1A1LMNARAB9AGCGR
SCHEMBL2499200 0.90 MAPT (0.60) MAPTALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL5685561 0.84 ALDH1A1 (0.56) MAPTALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL10441459 0.84 GAA (0.55) ALDH1A1RAB9AMEN1KMT2AHTT
SCHEMBL8597038 0.84 TSHR (0.56) MAPTALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL7455682 0.83 RAB9A (0.51) MAPTALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL6280628 0.82 PTPN1 (0.54) MAPTALDH1A1LMNARAB9AGCGR
SCHEMBL7455153 0.82 SMPD1 (0.57) MAPTALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL2395083 0.78 ALDH1A1 (0.65) MAPTALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL28500412 0.77 MAPT (0.67) MAPTALDH1A1RAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921827-B2 Process for preparing 3-aryl-benzo{b} thiophenes ELI LILLY AND COMPANY (US) 2005-07-26 US disclosed
US-20040132775-A1 Process for preparing 3-aryl-benzo{b} thiophenes LUKE WAYNE DOUGLAS (US) 2004-07-08 US disclosed
WO-2002042261-A2 PROCESS FOR PREPARING α-(3-ARYLTHIO)-ACETOPHENONES ELI LILLY AND COMPANY (US) 2002-05-30 WO disclosed
US-4075227-A NONSTEROIDAL ELI LILLY AND COMPANY (US) 1978-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132775-A1 Process for preparing 3-aryl-benzo{b} thiophenes TBCB, CYP1B1, TST MAPT 2868/4885ALDH1A1 2025/4885LMNA 1270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.